Chinese robotics firm Unitree will list on the Shanghai STAR Market on August 19, having raised 6.1 billion yuan in an IPO. The company recently showcased a new 'Superman' humanoid robot, though its high-performance claims currently lack independent verification. Investors should monitor the company's high valuation and potential trade-related risks as it enters the public market.
Hangzhou-based Unitree Robotics is preparing for its highly anticipated debut on the Shanghai STAR Market on August 19, 2026. The listing follows an initial public offering that successfully raised 6.1 billion yuan, with shares priced at 150.80 yuan. The IPO attracted significant retail investor attention, with subscription demand exceeding the available shares by more than 8,000 times.
Ahead of this debut, the company unveiled a prototype humanoid robot dubbed 'Superman.' Unitree claims the machine can achieve a standing jump of two meters and reach a top speed of 12.66 meters per second. The company states these figures outperform current human records. However, it is important for investors to note that these performance metrics are based on company-led demonstrations and have not yet been independently verified or certified by external technical bodies.
Unitree has gained traction in the robotics sector by delivering approximately 18,000 bipedal humanoid robots to date. The company reported revenue of 1.70 billion yuan for 2025, with its humanoid robotics segment serving as the primary driver of its business. As the firm transitions to a publicly traded entity, it faces the challenge of scaling production while maintaining technological leadership in a highly competitive and evolving industry.
The company’s valuation, with a price-to-earnings (P/E) ratio exceeding 219x, reflects substantial market expectations for future growth. Such high valuations typically imply that investors have priced in rapid expansion and significant technological breakthroughs. Beyond valuation concerns, the company also faces potential business pressure from global trade dynamics, including ongoing U.S.-China technology export restrictions, which could impact its international sales and growth trajectory.
As the stock begins trading on the STAR Market tomorrow, market participants will be watching to see how the company balances its rapid development cycles with the need for sustained financial performance and the validation of its ambitious technological claims.